Industry News (Acquisitions)

Rights to New Therapeutic AIDS Vaccine Acquired

Published in AIDS Weekly, December 15th, 1997

ID Biomedical Corp., Vancouver, British Columbia, announced that its vaccine subsidiary, ID Vaccine Corp., has secured the worldwide rights to a new therapeutic vaccine being developed for AIDS.

The vaccine aims to prevent or delay the onset of AIDS in people infected with HIV. The use of the vaccine to prevent HIV infection is also being investigated.

The vaccine was developed by Dr. Arye Rubinstein, MD, Albert Einstein College of Medicine of Yeshiva University (AECOM) in New York, New York. He said in initial human tests on a small scale in Israel, the new vaccine achieved better reduction in viral load than any other HIV vaccine currently in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry